glp-1 receptor agonist natural Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Managing Side Effects of GLP-1

"These new vials not only help us meet the high demand for our obesity medicine, but also broaden access for patients seeking a safe and effective treatment option

Vulnerability Nodes Under Chronic Flux Constriction Chronic reductions in nutrient inflow during GLP-1RA therapy do not simply alter energy balance but reshape the metabolic boundary conditions governing systemic homeostasis

Wootten D, Reynolds CA, Smith KJ, Mobarec JC, Koole C, Savage EE, et al

Reuters and BBC both indicate that while the opportunity is huge, so are the concerns around misuse and regulation

Boehringer reported that Jardiance generated 8.36 billion ($9.04 billion) in annual sales, marking a 13.2% increase over 2023

Figure 3 (below) provides an overview of the nature of these unmet needs, as well as strategies and the level of competition to address them (based on current clinical development pipelines)